The impact of aromatic ring count on compound developability--are too many aromatic rings a liability in drug design?

762 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Lipophilicity in drug discovery (2010, background): “Along these lines, it has been suggested that reduction of molecular weight [21,35,40], removal of aromatic rings [75] and increased saturation or added chirality [76] might offer generic means of achieving this.”
The Structure and Function of DNA G-Quadruplexes (2020, background): “optimal for a small molecule with good pharmacokinetic properties [34,35].”
Quantifying the chemical beauty of drugs. (2012, background): “, number of hydrogen bond donors (HBDs), number of hydrogen bond acceptors (HBAs), molecular polar surface area (PSA), number of rotatable bonds (ROTBs), number of aromatic rings (AROMs”
Molecular obesity, potency and other addictions in drug discovery (2011, background): “While clearly related in a non-linear manner to lipophilicity, the analysis of this property by Ritchie and MacDonald gives interesting insights which can be summarized as “the fewer aromatic rings in an oral drug candidate the better” with less than three being suggested as an appropriate target nu”